CYP1B1 and acute kidney injury: It has been shown to be capable of metabolizing anticancer drugs such as docetaxel, cisplatin, tamoxifen, and nucleoside analogs [24] and is involved in AKI since the complement system induced a significant CYP1B1 level increase, modulating its gene DNA methylation [25,34,35].